Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,228 total articles

FuboTV COO Offloads $1.46M in Shares, Ends Direct Stake

FuboTV COO Offloads $1.46M in Shares, Ends Direct Stake

Alberto Horihuela, Chief Operating Officer of FuboTV Inc. (NASDAQ:FUBO), executed a significant divestment of his equity position, selling 141,074 shares of Class A Common Stock on June 11, 2026. The transaction, valued at $1,464,291, leaves the executive with a zero direct shareholding. This sale transpires against a backdrop of mixed corporate pe…

East West Bancorp Executive Insider Sale at Peak Valuation

East West Bancorp Executive Insider Sale at Peak Valuation

Irene Oh, East West Bancorp's Chief Risk Officer, executed a sale of 500 shares in the company on June 12, 2026. The transaction, valued at $66,250, was executed at a weighted average price of $132.50 per share. This sale reduces her direct holdings to 85,498 shares, while she maintains an additional 2,508 shares through a 401(k) plan. The transact…

Silver Lake Affiliates and Dell Director Durban Liquidate $9.43M in Class C Shares Amid Valuation Signals

Silver Lake Affiliates and Dell Director Durban Liquidate $9.43M in Class C Shares Amid Valuation Signals

Entities linked to Silver Lake and Dell Technologies director Egon Durban executed a combined sale of 23,876 Class C common shares on June 10, 2026, realizing approximately $9.43 million. The transaction occurred as Dell's stock traded near $395.57, a level that reflects a substantial 254% gain over the preceding twelve months. This activity unfold…

Ligand Pharmaceuticals Director Jason Aryeh Offloads $1.25M in Shares Amid Valuation Concerns and Merger Activity

Ligand Pharmaceuticals Director Jason Aryeh Offloads $1.25M in Shares Amid Valuation Concerns and Merger Activity

Jason Aryeh, a director at Ligand Pharmaceuticals Inc (NASDAQ:LGND), executed a series of sales totaling 5,000 shares of common stock valued at approximately $1.25 million. The divestment occurred as the company's shares approached a 52-week high of $258.56, despite the stock appearing overvalued relative to its fair value according to recent analy…

Gen Digital Director Ondrej Vlcek Offloads $2.48M in Equity

Gen Digital Director Ondrej Vlcek Offloads $2.48M in Equity

Ondrej Vlcek, a director at Gen Digital Inc. (NASDAQ: GEN), executed a significant equity transaction on June 10, 2026, selling 100,000 shares of the company's common stock. The transaction, valued at $2,478,300, reflects a weighted average sale price of $24.783 per share. Despite this divestment, Vlcek retains substantial ownership, with direct ho…

Warby Parker Director Moon Youngme E Executes $265,300 Share Disposition Amid Strategic Product Launches

Warby Parker Director Moon Youngme E Executes $265,300 Share Disposition Amid Strategic Product Launches

Warby Parker Inc. (NASDAQ:WRBY) Director Moon Youngme E has completed the sale of 10,000 shares of the company's Class A Common Stock, with the transaction totaling $265,300. This disposal follows a period of significant stock price appreciation and coincides with the company's recent introduction of its first Intelligent Eyewear frame in partnersh…

Live Oak Bancshares CEO James S. Mahan III Sells $769k in Stock

Live Oak Bancshares CEO James S. Mahan III Sells $769k in Stock

James S. Mahan III, Chief Executive Officer, Director, and a ten percent owner of Live Oak Bancshares, Inc. (NASDAQ:LOB), recently sold shares of the company’s voting common stock totaling $769,172. The transactions occurred over two days, June 10 and June 11, 2026. The sales come as Live Oak shares trade at $39.03, up 35% over the past year. Accor…